CAMAROS Trial

The CAMAROS trial is a multicentre, randomized, double-blinded, controlled phase II trial analyzing the effect of coupling a C-C chemokine receptor 5 (CCR5) antagonist, Maraviroc (Celsentri), and exercise to improve both upper and lower extremity recovery after a stroke.